Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06690736

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

Conditions: CXCR4-related Disease, Tumor, Positron Emission Tomography, Metastasis

Sex: All

Ages: 18 Years – 80 Years

Healthy volunteers: Yes

Phase: NA

Enrollment: 200

Sponsor: Tianjin Medical University

Location: The First Affiliated Hospital of University of Science and Technology of China Hefei Anhui

Summary

To evaluate the potential usefulness of 68Ga/18F-Pentixafor/Pentixather positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various CXCR4-related disease patients.

Eligibility Criteria

Inclusion Criteria: * suspected or confirmed untreated Lymphoproliferative and other CXCR4-related diseases patients * 18F-FDG PET/CT within two weeks * signed written consent. Exclusion Criteria: * pregnancy * breastfeeding * known allergy against Pentixafor

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06690736). StuddyBuddy aggregates publicly available trial information.